US Stock MarketDetailed Quotes

BIO Bio-Rad Laboratories

Watchlist
  • 265.160
  • -0.470-0.18%
Close Feb 28 16:00 ET
  • 265.160
  • 0.0000.00%
Post 16:55 ET
7.43BMarket Cap-4.06P/E (TTM)

Bio-Rad Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bio-Rad Laboratories Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
679.75M
667.48M
-12.28M
Miss Est.
-0.21%
-2.00%
-1.81%
EPS
--
-25.57
--
-310.63%
Analyst Rating
Buy

Feb 28, 2025

Bio-Rad Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 635.806M--
--2025/Q1-- / 573.329M--
Feb 13, 20252024/Q4667.500M / 679.754M--
Oct 30, 20242024/Q3649.729M / 628.614M--
Aug 1, 20242024/Q2638.476M / 646.404M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 635.806M--
--2025/Q1-- / 573.329M--
Feb 13, 20252024/Q4667.500M / 679.754M--
Oct 30, 20242024/Q3649.729M / 628.614M--
Aug 1, 20242024/Q2638.476M / 646.404M--

Unlock Free Earnings Estimates

Bio-Rad Laboratories Earnings Reports

  • Bio-Rad Laboratories | 10-K: FY2024 Annual Report

    Feb 14 16:38 ET

  • Bio-Rad Laboratories | 8-K: Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

    Feb 13 16:30 ET

  • Bio-Rad Laboratories | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 16:23 ET

  • Bio-Rad Laboratories | 8-K: Bio-Rad Reports Third-Quarter 2024 Financial Results

    Oct 30, 2024 16:25 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data